Lorcaserin Extended-Release Tablets and Paraplatin NovaPlus
Determining the interaction of Lorcaserin Extended-Release Tablets and Paraplatin NovaPlus and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: lorcaserin
Brand name: Belviq, Belviq XR
Synonyms: Lorcaserin
Generic Name: carboplatin
Brand name: Paraplatin, CARBOplatin Novaplus
Synonyms: Paraplatin
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Lorcaserin Extended-Release Tablets-Parathyroid hormone
- Lorcaserin Extended-Release Tablets-Parathyroid hormone Subcutaneous
- Lorcaserin Extended-Release Tablets-Parcopa
- Lorcaserin Extended-Release Tablets-Paregoric
- Lorcaserin Extended-Release Tablets-Paremyd
- Lorcaserin Extended-Release Tablets-Paremyd Ophthalmic
- Paraplatin NovaPlus-Lorcaserin Hydrochloride
- Paraplatin NovaPlus-Lorcaserin Tablets
- Paraplatin NovaPlus-Lorcet
- Paraplatin NovaPlus-Lorcet Plus
- Paraplatin NovaPlus-Lorcet Tablets
- Paraplatin NovaPlus-Lorlatinib